Blog
RSS FeedPosted by Michael Wonder on 01 Jul 2018
Private health insurance a hard sell to Medicare generation
30 June 2018 - The Coalition’s health insurance reforms are needed to prevent a decade-long decline in the sector, according ...
Posted by Michael Wonder on 01 Jul 2018
NICE rejects ocrelizumab (Ocrevus) for primary progressive MS in England and Wales
29 June 2018 - The MS Trust is very disappointed that NICE is unable to recommend ocrelizumab as an NHS treatment ...
Posted by Michael Wonder on 01 Jul 2018
A drug that elongates life in breast cancer patients listed on PBS today - but only for some
1 July 2018 - They are two women from the same city who have exactly the same deadly disease. ...
Posted by Michael Wonder on 30 Jun 2018
New Zealand Pharmaceutical Schedule - 1 July 2018 update
1 July 2018 - The July 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Jun 2018
Price of breast cancer drug ribociclib cut after being placed on Pharmaceutical Benefits Scheme
30 June 2018 - The breast cancer drug ribociclib has been placed on the Pharmaceutical Benefits Scheme, taking the price from ...
Posted by Michael Wonder on 30 Jun 2018
Schedule of Pharmaceutical Benefits - 1 July 2018 update
1 July 2018 - The July 2018 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Jun 2018
PBS and NIP cost recovery - annual indexation of fees
1 July 2018 - The recovery of fees associated with the evaluation and listing of medicines, vaccines and other products ...
Posted by Michael Wonder on 28 Jun 2018
'Not at a crisis point yet': Doctors defend going private to give birth
29 June 2018 - A decline in the numbers of women giving birth through the private health system, and associated ...
Posted by Michael Wonder on 28 Jun 2018
High cost specialty drugs continue to dominate the new drug landscape
26 June 2018 - The Patented Medicine Prices Review Board, through the National Prescription Drug Utilisation Information System research initiative, ...
Posted by Michael Wonder on 28 Jun 2018
NICE backs Roche’s Alecensa
28 June 2018 - Roche’s Alecensa has won NICE backing as a treatment for a rare type of lung cancer, ...
Posted by Michael Wonder on 27 Jun 2018
New from CADTH: procedural guidelines and a streamlined therapeutic review framework
27 June 2018 - Recent changes continue to strengthen the Pharmaceutical Reviews portfolio and help CADTH adapt quickly to the changing ...
Posted by Michael Wonder on 27 Jun 2018
Improving access to new treatments in rare diseases
21 June 2018 - Emily Crossley, co-founder and co-chief executive of Duchenne UK, tells us how a ground-breaking HERCULES project ...
Posted by Michael Wonder on 26 Jun 2018
New uses for old drugs
26 June 2018 - Low cost generics are an untapped source of therapeutic innovation. ...
Posted by Michael Wonder on 26 Jun 2018
Celebrating 25 years of PHARMAC
26 June 2018 - Health Minister Dr David Clark is pleased to mark 25 years since the establishment of the ...
Posted by Michael Wonder on 26 Jun 2018
Health cap to leave insurers on the brink
27 June 2018 - Labor’s proposed 2% cap on health insurance premium increases would lead to eight insurers operating at ...